AE Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Buy |
2,633
+408
| +18% | +$214K | 0.01% | 634 |
|
|
2025
Q1 | $1.41M | Buy |
2,225
+445
| +25% | +$282K | 0.01% | 622 |
|
|
2024
Q4 | $1.27M | Buy |
1,780
+706
| +66% | +$503K | 0.01% | 650 |
|
|
2024
Q3 | $1.13M | Buy |
1,074
+527
| +96% | +$554K | 0.01% | 668 |
|
|
2024
Q2 | $575K | Buy |
547
+89
| +19% | +$93.5K | 0.01% | 849 |
|
|
2024
Q1 | $441K | Sell |
458
-3,210
| -88% | -$3.09M | 0.01% | 855 |
|
|
2023
Q4 | $3.45M | Buy |
3,668
+2,450
| +201% | +$2.3M | 0.02% | 717 |
|
|
2023
Q3 | $1M | Sell |
1,218
-2,031
| -63% | -$1.67M | 0.01% | 1092 |
|
|
2023
Q2 | $2.33M | Sell |
3,249
-631
| -16% | -$453K | 0.01% | 799 |
|
|
2023
Q1 | $3.19M | Sell |
3,880
-677
| -15% | -$556K | 0.02% | 640 |
|
|
2022
Q4 | $3.29M | Sell |
4,557
-8,384
| -65% | -$6.05M | 0.02% | 589 |
|
|
2022
Q3 | $8.91M | Buy |
12,941
+82
| +0.6% | +$56.5K | 0.07% | 302 |
|
|
2022
Q2 | $7.6M | Buy |
12,859
+2,845
| +28% | +$1.68M | 0.06% | 334 |
|
|
2022
Q1 | $6.99M | Buy |
10,014
+176
| +2% | +$123K | 0.05% | 361 |
|
|
2021
Q4 | $6.21M | Buy |
9,838
+5,658
| +135% | +$3.57M | 0.04% | 377 |
|
|
2021
Q3 | $2.53M | Sell |
4,180
-169
| -4% | -$102K | 0.02% | 572 |
|
|
2021
Q2 | $2.43M | Buy |
4,349
+601
| +16% | +$336K | 0.02% | 574 |
|
|
2021
Q1 | $1.77M | Buy |
3,748
+3,044
| +432% | +$1.44M | 0.02% | 601 |
|
|
2020
Q4 | $340K | Sell |
704
-1,436
| -67% | -$694K | ﹤0.01% | 1089 |
|
|
2020
Q3 | $1.2M | Buy |
2,140
+236
| +12% | +$132K | 0.02% | 581 |
|
|
2020
Q2 | $1.19M | Buy |
1,904
+514
| +37% | +$320K | 0.02% | 563 |
|
|
2020
Q1 | $679K | Buy |
1,390
+808
| +139% | +$395K | 0.02% | 586 |
|
|
2019
Q4 | $219K | Buy |
+582
| New | +$219K | ﹤0.01% | 1034 |
|
|
2019
Q3 | – | Sell |
-705
| Closed | -$221K | – | 1046 |
|
|
2019
Q2 | $221K | Buy |
+705
| New | +$221K | 0.01% | 865 |
|
|
2018
Q1 | – | Sell |
-548
| Closed | -$206K | – | 451 |
|
|
2017
Q4 | $206K | Buy |
+548
| New | +$206K | 0.02% | 393 |
|